DRUG CONTAINING CATIONIZED CHITOSAN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160193244A1
SERIAL NO

14911793

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A task of the invention is to provide an art that inhibits the hemorrhagic activity exhibited by sulfated glycosaminoglycans, as well as a material, a medical material, and a drug that use a sulfated glycosaminoglycan while being free of the hemorrhaging problems caused by sulfated glycosaminoglycans and that can exhibit an excellent therapeutic effect on biological tissues. The present invention relates to an inhibitor of the hemorrhagic activity originating from sulfated glycosaminoglycans, the inhibitor having a cationized chitosan as an active ingredient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEIKAGAKU CORPORATIONTOKYO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
MUNEMURA, Yuichi Tokyo, JP 2 19
OTA, Naoki Tokyo, JP 130 3978
OTSUKA, Akira Tokyo, JP 58 915

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation